本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Travere Therapeutics, Inc.

16.11
-0.4000-2.42%
盤後16.110.00000.00%16:33 EDT
成交量:144.38萬
成交額:2,354.24萬
市值:14.31億
市盈率:-5.81
高:16.74
開:16.65
低:16.10
收:16.51
資料載入中...
2021/07/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/10

重要事件披露

8-K - Current report
2021/05/25

重要事件披露

8-K - Current report
2021/05/19

重要事件披露

8-K - Current report
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

重要事件披露

8-K - Current report
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

重要事件披露

8-K - Current report
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

重要事件披露

8-K - Current report
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals